KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

NovoCure (NVCR) Times Interest Earned (2016 - 2022)

NovoCure's Times Interest Earned history spans 9 years, with the latest figure at -$9.48 for Q2 2022.

  • On a quarterly basis, Times Interest Earned rose 27.5% to -$9.48 in Q2 2022 year-over-year; TTM through Mar 2023 was -$66.86, a 909.94% decrease, with the full-year FY2021 number at -$5.73, down 331.66% from a year prior.
  • Times Interest Earned hit -$9.48 in Q2 2022 for NovoCure, down from -$0.47 in the prior quarter.
  • Over the last five years, Times Interest Earned for NVCR hit a ceiling of $3.77 in Q3 2020 and a floor of -$13.08 in Q2 2021.
  • Historically, Times Interest Earned has averaged -$2.27 across 5 years, with a median of -$1.79 in 2018.
  • Biggest five-year swings in Times Interest Earned: surged 4121.37% in 2020 and later tumbled 1318.08% in 2022.
  • Tracing NVCR's Times Interest Earned over 5 years: stood at -$4.01 in 2018, then soared by 102.19% to $0.09 in 2019, then surged by 4121.37% to $3.7 in 2020, then plummeted by 390.65% to -$10.76 in 2021, then grew by 11.85% to -$9.48 in 2022.
  • Business Quant data shows Times Interest Earned for NVCR at -$9.48 in Q2 2022, -$0.47 in Q1 2022, and -$10.76 in Q4 2021.